Sage Therapeutics/$SAGE
About Sage Therapeutics
Ticker
Industry
Employees
SAGE Metrics
$459M
-
-$5.59
0.91
-
Price and volume
Market cap
$459M
Beta
0.91
52-week high
$27.68
52-week low
$4.62
Average daily volume
1.6M
Financial strength
Current ratio
10.015
Quick ratio
9.721
Long term debt to equity
1.847
Total debt to equity
1.862
Management effectiveness
Return on assets (TTM)
-29.62%
Return on equity (TTM)
-49.34%
Valuation
Price to revenue (TTM)
4.261
Price to book
0.83
Price to tangible book (TTM)
0.83
Price to free cash flow (TTM)
-1.417
Growth
Revenue change (TTM)
837.60%
Earnings per share change (TTM)
-49.16%
3-year revenue growth (CAGR)
-54.29%
3-year earnings per share growth (CAGR)
-20.36%
What the Analysts think about SAGE
Analyst Ratings
SAGE Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
SAGE Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
SAGE News
FAQs
What’s the current market cap for Sage Therapeutics stock?
What is the P/E ratio for Sage Therapeutics stock?
Does Sage Therapeutics stock pay dividends?
No, Sage Therapeutics (SAGE) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Sage Therapeutics dividend payment date?
Sage Therapeutics (SAGE) stock does not pay dividends to its shareholders.
What is the beta indicator for Sage Therapeutics?
Sage Therapeutics (SAGE) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.